Related Experiment Video
Updated: Jun 12, 2026

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
L1 cell adhesion molecule is a novel therapeutic target in intrahepatic cholangiocarcinoma
Jeong-Ki Min1, Jin-Man Kim, Shengjin Li
1Therapeutic Antibody Research Center, Korea Research Institute of Bioscience and Biotechnology, Chungnam National University School of Medicine, Daejon, Korea.
Purpose:
Intrahepatic cholangiocarcinoma (ICC), a highly malignant hepatobiliary cancer, has a poor prognosis and is refractory to conventional therapies. The aim of this study is to discover a novel molecular target for the treatment of ICC.
Experimental Design:
To discover novel cancer-associated membrane antigens expressed in ICC cells, we generated monoclonal antibodies (mAb) by immunizing mice with intact ICC cell lines and screened for those that bind to the plasma membrane of ICC cells but not to normal cells. The mAb A10-A3 was selected and its target antigen was identified as the L1 cell adhesion molecule. Expression of L1 in ICC was evaluated by immunohistochemical analysis of tumor samples from 42 ICC patients. The functional significance of L1 expression in the tumor progression of ICC was investigated by L1 suppression, L1 overexpression, and antibody treatment.
Results:
L1 was not expressed in normal hepatocytes and intrahepatic bile duct epithelium but highly expressed in 40.5% of ICC patients, remarkably at the invasive front of the tumors. Suppression of L1 with short hairpin RNA significantly decreased proliferation, migration, and invasion of ICC cells in vitro. Consistently, L1 overexpression in ICC cells enhanced proliferation, migration, invasion, and apoptosis resistance. In addition, L1 short hairpin RNA or anti-L1 mAb significantly reduced the tumor growth in nude mice bearing ICC xenograft.
Conclusions:
We identified that L1 is expressed in ICC. L1 plays an important role in the tumor progression of ICC by enhancing cell proliferation, migration, invasion, and survival. L1 may represent a novel therapeutic target for ICC.
Insights
L1 cell adhesion molecule is highly expressed in intrahepatic cholangiocarcinoma (ICC), promoting tumor progression. Targeting L1 may offer a new therapeutic strategy for this aggressive cancer.
Area of Science:
- Hepatobiliary oncology
- Cancer immunology
- Molecular oncology
Background:
- Intrahepatic cholangiocarcinoma (ICC) is a malignant hepatobiliary cancer with poor prognosis.
- Conventional therapies for ICC are often ineffective.
- Novel molecular targets are needed for effective ICC treatment.
Purpose of the Study:
- To identify a novel molecular target for ICC treatment.
- To discover cancer-associated membrane antigens in ICC cells.
Main Methods:
- Generated monoclonal antibodies (mAb) against ICC cell lines.
- Screened mAbs for binding to ICC plasma membranes but not normal cells.
- Identified L1 cell adhesion molecule as the target antigen.
- Evaluated L1 expression in 42 ICC patient samples via immunohistochemistry.
- Investigated L1's functional role in ICC progression through suppression, overexpression, and antibody treatment.
Main Results:
- L1 was highly expressed in 40.5% of ICC patients, particularly at the invasive front.
- L1 expression was absent in normal hepatocytes and bile duct epithelium.
- L1 suppression decreased ICC cell proliferation, migration, and invasion in vitro.
- L1 overexpression enhanced ICC cell proliferation, migration, invasion, and apoptosis resistance.
- L1 suppression or anti-L1 mAb treatment reduced ICC xenograft tumor growth in vivo.
Conclusions:
- L1 is expressed in ICC and significantly contributes to tumor progression.
- L1 enhances ICC cell proliferation, migration, invasion, and survival.
- L1 represents a promising novel therapeutic target for intrahepatic cholangiocarcinoma.
Related Concept Videos
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Selectins
Intracellular Signaling Affects Focal Adhesions
Some...
Cell Adhesion Molecules - Types and Functions
CAM Families
The Integrin family of proteins is primarily involved in a...
